| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AMICUS THERAPEUTICS INC | 1,404,667 | 19,651,000 | 11.38% | ||
| 2 | EXELIXIS INC | 1,880,004 | 10,547,000 | 6.11% | ||
| 3 | NEURODERM LTD | 496,630 | 10,265,000 | 5.94% | ||
| 4 | Ascendis Pharma | 469,893 | 8,317,000 | 4.81% | ||
| 5 | ISHARES TR | 70,000 | 7,645,000 | 4.43% | Put | |
| 6 | Lion Biotechnologies | 1,314,959 | 7,574,000 | 4.38% | ||
| 7 | BIOTELEMETRY INC COM | 450,000 | 5,508,000 | 3.19% | ||
| 8 | CYNAPSUS THERAPEUTICS INC | 313,524 | 5,070,000 | 2.94% | ||
| 9 | SPDR SER TR | 70,000 | 4,357,000 | 2.52% | Put | |
| 10 | LEXICON PHARMACEUTICALS | 400,000 | 4,296,000 | 2.49% | ||
| 11 | VERACYTE INC | 905,000 | 4,244,000 | 2.46% | ||
| 12 | RR MEDIA LTD | 469,350 | 3,849,000 | 2.23% | ||
| 13 | PERNIX THERAPEUTICS HLDGS IN | 1,108,719 | 3,504,000 | 2.03% | ||
| 14 | Innocoll | 273,981 | 3,430,000 | 1.99% | ||
| 15 | LA JOLLA PHARMACEUTICAL CO | 122,222 | 3,397,000 | 1.97% | ||
| 16 | Nabriva Therapeutics AG | 351,261 | 3,337,000 | 1.93% | ||
| 17 | CAS MED SYS INC | 2,547,299 | 3,184,000 | 1.84% | ||
| 18 | WebMD Health Corp | 79,702 | 3,175,000 | 1.84% | ||
| 19 | BIOCRYST PHARMACEUTICALS | 271,399 | 3,094,000 | 1.79% | ||
| 20 | SPECTRANETICS CORP | 260,000 | 3,065,000 | 1.77% | ||
| 21 | IRIDEX CORP COM | 397,196 | 3,023,000 | 1.75% | ||
| 22 | SPECTRANETICS CORP | 4,000,000 | 3,020,000 | 1.75% | PRN | |
| 23 | IMMUNOMEDICS INC | 1,711,067 | 2,943,000 | 1.70% | ||
| 24 | APPLIED GENETIC TECHNOL CORP | 221,138 | 2,906,000 | 1.68% | ||
| 25 | BUILD A BEAR WORKSHOP COM | 152,876 | 2,888,000 | 1.67% | ||
| 26 | SAGENT PHARMACEUTICALS INC | 182,618 | 2,800,000 | 1.62% | ||
| 27 | SORRENTO THERAPEUTICS INC COM NEW | 300,000 | 2,517,000 | 1.46% | ||
| 28 | Oxford Immunotec Global PLC | 184,746 | 2,494,000 | 1.44% | ||
| 29 | AGENUS INC | 510,000 | 2,346,000 | 1.36% | ||
| 30 | ARRAY BIOPHARMA INC COM | 480,020 | 2,189,000 | 1.27% | ||
| 31 | ALIMERA SCIENCES INC | 974,318 | 2,153,000 | 1.25% | ||
| 32 | AXOVANT SCIENCES LTD | 140,000 | 1,809,000 | 1.05% | ||
| 33 | EPIZYME INC COM | 140,000 | 1,800,000 | 1.04% | ||
| 34 | ESSA Pharma | 288,400 | 1,797,000 | 1.04% | ||
| 35 | ZAFGEN INC COM | 51,519 | 1,646,000 | 0.95% | ||
| 36 | CARROLS RESTAURANT GROUP INC | 128,643 | 1,531,000 | 0.89% | ||
| 37 | CUTERA INC COM | 116,921 | 1,529,000 | 0.89% | ||
| 38 | CLOVIS ONCOLOGY INC | 15,000 | 1,379,000 | 0.80% | Call | |
| 39 | BioDelivery Sciences International Inc | 212,100 | 1,179,000 | 0.68% | ||
| 40 | BIODEL INC | 2,548,830 | 1,121,000 | 0.65% | ||
| 41 | AURINIA PHARMACEUTICALS INC | 377,427 | 1,072,000 | 0.62% | ||
| 42 | FLEX PHARMA INC COM | 88,716 | 1,065,000 | 0.62% | ||
| 43 | SAREPTA THERAPEUTICS INC | 31,744 | 1,019,000 | 0.59% | ||
| 44 | COMBIMATRIX CORPORATION | 893,644 | 1,001,000 | 0.58% | ||
| 45 | Agile Therapeutics, Inc. | 141,309 | 952,000 | 0.55% | ||
| 46 | ISHARES INC | 50,000 | 896,000 | 0.52% | Put | |
| 47 | CELLADON CORP | 819,710 | 861,000 | 0.50% | ||
| 48 | CARDIOME PHARMA CORP | 92,397 | 780,000 | 0.45% | ||
| 49 | CIDARA THERAPEUTICS INC | 59,127 | 752,000 | 0.44% | ||
| 50 | CARDICA INC | 1,849,436 | 499,000 | 0.29% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001493152-15-005571, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
